DOI:
10.1055/s-00000105
Zentralblatt für Gynäkologie
LinksClose Window
References
Tan-Chiu E, Yothers G, Romond E. et al.
Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node positive human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP-B31.
J Clin Oncol 2005; 23: 7811-7819
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.